tiprankstipranks
Top Stocks
U.S. Stock Market OverviewTop Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
Top ETFs by AUMSPY ETFQQQ ETF
Stock Comparison
Energy StocksOil StocksBest Value StocksAirline StocksElectric Vehicle StocksMATANA Stocks
New
Bank StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
Global Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsPre-Market BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsTools for Trading PlatformsData for Hedge FundsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Top ETFs by AUM
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
U.S. Markets
Market Movers
Expert Center
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
Top ETFs by AUM
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Energy Stocks
EV Stocks
Crypto News
Dividend Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Pre-Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

IOVA Stock Latest News

IOVA Up after Analyst Upgrade
Market NewsIOVA Up after Analyst Upgrade
2d ago
IOVA
Iovance Biotherapeutics upgraded to Overweight from Neutral at Piper Sandler
The FlyIovance Biotherapeutics upgraded to Overweight from Neutral at Piper Sandler
2d ago
IOVA
Iovance Biotherapeutics price target raised to $17 from $16 at Truist
The FlyIovance Biotherapeutics price target raised to $17 from $16 at Truist
5d ago
IOVA
Clinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M
The FlyClinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M
6d ago
IOVA
Iovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates
Press ReleasesIovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates
6d ago
IOVA
Akero Therapeutics appoints Patrick Lamy as SVP, commercial strategyIovance Biotherapeutics
The FlyAkero Therapeutics appoints Patrick Lamy as SVP, commercial strategyIovance Biotherapeutics
19d ago
AKRO
IOVA
Barclays views GSK acquisition interest as positive for oncology stocks
The FlyBarclays views GSK acquisition interest as positive for oncology stocks
27d ago
GSK
ARVN
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
2M ago
AA
CS
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
The FlyIovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
2M ago
IOVA
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
2M ago
PLX
CDMO
Here’s Why Iovance Biotherapeutics (NASDAQ:IOVA) Stock is Trending Higher
Market NewsHere’s Why Iovance Biotherapeutics (NASDAQ:IOVA) Stock is Trending Higher
2M ago
IOVA
Iovance rallies after director buys $65M worth of shares
The FlyIovance rallies after director buys $65M worth of shares
2M ago
IOVA
Iovance Biotherapeutics to Present at Upcoming Conferences
Press ReleasesIovance Biotherapeutics to Present at Upcoming Conferences
2M ago
IOVA
Iovance Biotherapeutics Tanks as FDA Requests More Data for Lifileuel
Market NewsIovance Biotherapeutics Tanks as FDA Requests More Data for Lifileuel
2M ago
IOVA
Iovance Biotherapeutics Provides Update on Biologics License Application Submission for Lifileucel in Advanced Melanoma
Press ReleasesIovance Biotherapeutics Provides Update on Biologics License Application Submission for Lifileucel in Advanced Melanoma
2M ago
IOVA
Society for Immunotherapy of Cancer to hold a meeting
The FlySociety for Immunotherapy of Cancer to hold a meeting
3M ago
LH
BMY
Iovance Biotherapeutics announces updated clinical data for lifileucel
The FlyIovance Biotherapeutics announces updated clinical data for lifileucel
3M ago
IOVA
Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Press ReleasesIovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
3M ago
IOVA
Society for Immunotherapy of Cancer to hold a meeting
The FlySociety for Immunotherapy of Cancer to hold a meeting
3M ago
LH
BMY
Iovance Biotherapeutics announces updated clinical data for Lifileucel
The FlyIovance Biotherapeutics announces updated clinical data for Lifileucel
3M ago
IOVA
Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Press ReleasesIovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
3M ago
IOVA
Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2022 Financial Results and Corporate Updates
Press ReleasesIovance Biotherapeutics Reports Third Quarter and Year-to-Date 2022 Financial Results and Corporate Updates
3M ago
IOVA
Iovance Biotherapeutics to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 3, 2022
Press ReleasesIovance Biotherapeutics to Host Third Quarter Financial Results Conference Call and Webcast on Thursday, November 3, 2022
3M ago
IOVA
Iovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
Press ReleasesIovance Biotherapeutics Announces First Patient Dosed with PD-1 Inactivated Tumor Infiltrating Lymphocyte (TIL) Therapy
4M ago
IOVA
Iovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Press ReleasesIovance Biotherapeutics to Present Clinical Data for Lifileucel Tumor Infiltrating Lymphocyte (TIL) Therapy in Advanced Melanoma at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
4M ago
IOVA
Iovance Biotherapeutics to Present at Upcoming Conferences
Press ReleasesIovance Biotherapeutics to Present at Upcoming Conferences
5M ago
IOVA
Iovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
Press ReleasesIovance Biotherapeutics Initiates Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma
5M ago
IOVA
Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates
Press ReleasesIovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates
6M ago
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Press ReleasesIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
6M ago
IOVA